Tasly Capital
Overview
Tasly Capital is a corporate venture capital firm investing in the healthcare and biotechnology sectors. It focuses on early-stage ventures in areas such as pharmaceuticals, medical devices, digital health, and health services. The firm operates primarily in China and Japan, aligning with its parent company's international presence. The firm's investment strategy encompasses a wide range of industries, including pharmaceuticals, medical equipment, health services, functional foods, and nutraceuticals. Tasly Capital seeks to support innovative companies that contribute to the advancement of healthcare and biotechnology. Tasly Capital is the investment arm of Tasly Holding Group, a Chinese pharmaceutical company established in 1994. The parent company is publicly listed on the Shanghai Stock Exchange, reflecting its significant presence in the pharmaceutical industry. Tasly Capital's investments are part of the group's broader strategy to promote health and wellness through various business segments, including pharmaceuticals, health products, and health management services.
Investment Focus
- Innovative healthcare and biotechnology solutions
- Early-stage ventures with growth potential
- Alignment with Tasly Holding Group's strategic interests
Portfolio Companies
Reach Tasly Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Tasly Capital
What sectors does Tasly Capital invest in?
Tasly Capital invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Biotechnology and Health Services, and is based in Tianjin, China. Tasly Capital is listed as a corporate vc in the ConnectSafely investor database.
Which regions does Tasly Capital invest in?
Tasly Capital invests across Japan and China.
What companies has Tasly Capital invested in?
Tasly Capital's portfolio includes Libo Biotech, Singular Medical, Yoshitsu, Lingbo Biotechnology (Hangzhou), Enrikenuo, PulseCare, LeadBio Tech and UniXell Biotechnology.
Last updated · Source: ConnectSafely investor database
